一个抗氧化剂的前循环,由链接组织素变异H1.2和NRF2协调,驱动非小细胞肺癌的进展
Yuchen Chen1, Jiajian Shi1, Xiaomu Wang2
1Tongji School of Pharmacy, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong University of Science and Technology, Wuhan 430030, China.
概括
希斯H1.2通过增强抗氧化剂反应,促进非小细胞肺癌 (NSCLC) 的进展和化学抵抗. 针对H1.2可能为NSCLC患者提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 非小细胞肺癌 (NSCLC) 呈现出高恶性和有限的治疗选择,基化疗耐药性是常见的挑战.
- NSCLC细胞利用增强的抗氧化防御系统来管理活性氧物种 (ROS),有助于瘤的进展和治疗耐药性,尽管潜在的机制需要进一步阐明.
- 基因组,特别是基因组变异H1.2 (H1C),与瘤进展和细胞抗氧化剂反应有关,但它们在NSCLC发展中的特定作用尚未完全理解.
研究的目的:
- 为了研究组织素H1.2在非小细胞肺癌 (NSCLC) 的发展和进展中的作用.
- 探索H1.2,抗氧化剂防御和NSCLC中的化学抵抗之间的机制联系.
- 确定H1.2作为NSCLC治疗点的潜力.
主要方法:
- 在NSCLC瘤中分析H1.2表达和与患者存活率的相关性.
- 使用小鼠NSCLC模型与H1.2淘汰赛来评估其对瘤进展,氧化应激和谷氨合成的影响.
- 研究H1.2和NRF2之间的相互作用,以及其对NRF2的核定位,稳定性和与GCLC促进体结合的影响.
主要成果:
- H1.2表达在NSCLC中升高,与较差的生存结果相关.
- 在小鼠NSCLC模型中的H1.2删除抑制了瘤进展,增加了氧化应激,并降低了谷氨 (GSH) 和GCLC水平.
- 高H1.2水平与增加的化疗药物耐药性 (IC50) 和NSCLC患者的更差预后相关.
- 缺少H1.2的NSCLC细胞在西斯治疗后显示生存率降低和ROS增加,这被ROS清理器所拯救.
- H1.2 与NRF2相互作用,增强其核存在和稳定性,从而促进NRF2介导的GCLC转录. NRF2还对H1.2进行上调,形成一个前循环.
结论:
- H1.2在NSCLC发育中起着显著的瘤促进作用.
- 一个新的H1.2-NRF2抗氧化剂前周期有助于NSCLC的进展和化学抵抗.
- 针对H1.2-NRF2轴是一个潜在的治疗策略,用于克服NSCLC的化学抵抗.
相关概念视频
NF-κB-dependent Signaling Pathway
7.5K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.5K
Electron Transport Chain: Complex I and II
14.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.4K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K


